Currently, the most effective strategy to prevent influenza is vaccination. While the traditional inactivated influenza vaccine demonstrates favorable safety and effectiveness, live attenuated influenza vaccine (LAIV) offers unique advantages. It has the capability to mimic natural infection through nasal administration and can be quickly prepared in the event of an influenza pandemic. The NS gene, encoding non-structural protein 1 (NS1) and nuclear export protein (NEP), represents the eighth segment of the influenza virus (FluV) genome and plays a crucial role in suppressing host cell interferon production and regulating the nuclear export process of ribonucleoprotein complex during FluV replication. Therefore, the NS gene has gradually become a key target for the development of LAIV in recent years. Manipulating the FluV genome using reverse genetics technology holds promise for enhancing its efficacy and safety as a vaccine vector against respiratory infectious diseases as well as an anti-tumor biological agent. This article provides a comprehensive overview of the research progress in utilizing modified NS FluV as live attenuated vaccines against influenza. Additionally, this review also explores the potential of using FluV with modified NS as vaccine vector for other infectious diseases and as gene therapy tool against tumors.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11880705 | PMC |
| http://dx.doi.org/10.1016/j.omtn.2025.102471 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Alphavirus nsP2: A Multifunctional Regulator of Viral Replication and Promising Target for Anti-Alphavirus Therapies.
Rev Med Virol
March 2025
Institute of Bioengineering, University of Tartu, Tartu, Estonia.
Alphaviruses are re-emerging vector-born pathogens that cause arthralgia or encephalitic diseases on a global scale. While a vaccine against chikungunya virus was recently approved, no vaccines currently exist for other alphaviruses, nor are there antiviral drugs for the treatment of alphavirus infections. Alphaviruses have positive-strand RNA genomes, and their RNA replication is coordinated by activities of the multifunctional nonstructural protein 2 (nsP2), a helicase-protease and a subunit of viral RNA replicase.
View Article and Find Full Text PDFEvaluation of an interferon-gamma release assay for early detection of lumpy skin disease virus infection and vaccination in cattle.
Microbiol Spectr
March 2025
Sciensano, Unit Exotic and Vector Borne Diseases (ExoVec), Brussels, Belgium.
Lumpy skin disease virus (LSDV) causes a nodular dermatitis in cattle and has high economic consequences in affected areas. Detection of LSDV exposure mostly relies on the humoral immune response, while the cell-mediated immune (CMI) response, an important hallmark of the immune reaction to LSDV, is neglected. We collected samples during 3 weeks post-vaccination of cattle with a Neethling-based live attenuated vaccine (LAV) and during 4 weeks post-LSDV infection under experimental conditions to i) investigate the development of the CMI response, ii) optimize an interferon-gamma release assay (IGRA) by comparing two matrices (whole blood and PBMCs) and different stimuli, and iii) evaluate the usefulness of an IGRA for detection of infection and vaccination.
View Article and Find Full Text PDFEarly Activation of Lung CD8 T Cells After Immunization with Live Malaria Sporozoites.
Pathog Immun
March 2025
Leiden University Centre for Infectious Diseases (LU-CID), Leiden University Medical Centre, The Netherlands.
Background: Two novel malaria vaccines, RTS,S and R21, mark a significant step forward in malaria research, but eradication demands vaccines with higher efficacy. Recent trials using late-arresting genetically attenuated parasites (LA-GAP) highlight their effectiveness as next-generation vaccines, likely through CD8 T-cell activation targeting late liver-stage parasites. However, the distribution of LA-GAP-activated T cells in different organs that culminate towards high-level protection in the liver remains unclear.
View Article and Find Full Text PDFInborn errors of immunity in Canadian First Nations and Nunavut Inuit Children: the tip of the iceberg.
Paediatr Child Health
February 2025
Departments of Pediatrics and Oncology, University of Calgary, Alberta Children's Hospital, Calgary, Alberta.
Objectives: Inborn errors of immunity (IEI) are a heterogeneous group of genetic diseases that impact normal immune development and function. Individual IEI are rare, but collectively, can represent an important health burden. Little is known about the types of IEI seen in Canadian First Nations (FN) and Inuit populations.
View Article and Find Full Text PDFVirulence attenuation of Theileria annulata-transformed macrophages.
Trends Parasitol
March 2025
Laboratoire de Biologie des Apicomplexes, Faculté de Médecine, Université Paris Descartes - Sorbonne Paris Cité, Paris, France; INSERM U1016, CNRS UMR8104, Cochin Institute, Paris, France. Electronic address:
Tropical theileriosis is a significant tick-borne disease affecting cattle. For decades an empirical live attenuated vaccine has been the primary method of controlling disease. The vaccine is produced through prolonged culture of Theileria annulata schizont-transformed macrophages, but how loss of virulence occurs remains unclear.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!